Specialist
Former Director at NHS England
Agenda
- Implications of NHS strategic initiatives on tech providers
- Underserved areas for tech investment
- Potential winners and losers among key players
Questions
1.
Can we start by outlining how the NHS is structured, and how funding and payment decisions are made?
2.
Can you elaborate on how the NHS is structured beneath NHS England, examining sustainability and transformation partnerships [STPs] and clinical commissioning groups [CCGs]?
3.
Do you think the introduction of integrated care systems [ICSs] will impact inter-dynamics for private players?
4.
Examining private opportunities available within the NHS, how would you say the willingness to shift money out of the system towards private players has evolved?
5.
To what extent would a shift to limiting private care within the NHS impact a private hospital provider such as Spire?
6.
Would a shift towards an integrated payer-provider system contribute to more winner-takes-all dynamics for private players? It would be easier to reach scale across the UK and more difficult, conversely, for smaller players to come in?
7.
Is there a specific amount earmarked for tech within the NHS? How does it work?
8.
Can you elaborate on primary care funding to contextualise our discussion on tech opportunities?
9.
Can you pinpoint the most interesting tech opportunities and players within primary care specifically?
10.
Which of the video consultation players have you been the most impressed by?
11.
Babylon would say that is not an issue with the disruptor, but rather with the payment system. How do you expect that to pan out for Babylon specifically over the next few years?
12.
How do you think a Labour government would impact the prospects of a player such as Babylon, if at all?
13.
We have yet to reach a definitive answer of what is possible regarding AI diagnoses. Do you have a strong view on the prospects for AIs such as symptom checker apps, which Babylon has?
14.
Do you think Babylon’s removal from the NHS’s Apps Library last year was a significant marker of the relationship between the two?
15.
Doctor appointment booking platforms such as France-based Doctolib are another area receiving attention. Do you think that segment could grow in the UK?
16.
Shifting to secondary care, can you describe the incumbents in electronic patient records [EPRs]?
17.
Have there been interesting areas of activity within social care for IT and tech providers?
18.
Do any tech players in the private market stand out as particularly smart or attractive as a growth platform, given your knowledge of NHS dynamics?
19.
The recent August NHS Long Term Plan draft had a whole chapter devoted to digital. Reading that plan, do you think that the willingness of the NHS to be open to disruptors has developed?
20.
Which types of care on the outpatient clinic side do you think have the largest opportunity for privates? There is a lot of private money flowing into fertility clinics, with the likes of The Fertility Partnership.
21.
Can we conclude by examining the broader funding situation for the NHS? A former Director of Strategy for NHS England and colleague of yours, Robert Harris, expects a large shortfall over the next couple of years. How significant do you think the shortfall will be?
